SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 260 filers reported holding SAGE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,577,000 | +67.0% | 77,866 | +123.7% | 0.04% | +68.0% |
| Q3 2021 | $1,543,000 | -91.2% | 34,813 | -85.2% | 0.02% | -93.6% |
| Q1 2021 | $17,547,000 | +9.9% | 234,434 | +27.0% | 0.39% | -8.0% |
| Q4 2020 | $15,966,000 | +41.1% | 184,558 | -0.3% | 0.42% | +14.0% |
| Q3 2020 | $11,315,000 | -5.5% | 185,134 | -35.7% | 0.37% | -21.7% |
| Q2 2020 | $11,973,000 | +162.5% | 287,943 | +81.3% | 0.47% | +45.4% |
| Q1 2020 | $4,562,000 | +211.4% | 158,827 | +682.7% | 0.33% | +443.3% |
| Q4 2019 | $1,465,000 | – | 20,292 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |